Rani Therapeutics Holdings (RANI) Current Leases (2022 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Current Leases of $1.5 million for Q1 2026, up 10.19% year-over-year from $1.3 million in Q1 2025, and down 7.94% quarter-over-quarter from $1.6 million in Q4 2025.
Rani Therapeutics Holdings (RANI) Current Leases (2022 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Current Leases history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Current Leases rose 10.19% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 10.19% YoY), while the FY2025 annual figure was $1.6 million, up 8.7% from the prior year.
- Current Leases for Q1 2026 stood at $1.5 million, down from $1.6 million in the prior quarter.
- The five-year high for Current Leases was $1.6 million in Q4 2025, with the low at $650000.0 in Q1 2022.
- The 5-year median for Current Leases is $1.0 million (2025), against an average of $1.1 million.
- The sharpest annual moves came in 2023 and 2024: Current Leases fell 28.63% in 2023, then soared 103.2% in 2024.
- Rani Therapeutics Holdings' Current Leases stood at $1.0 million in 2022, then dropped by 28.63% to $718000.0 in 2023, then jumped by 103.2% to $1.5 million in 2024, then gained by 8.7% to $1.6 million in 2025, then retreated by 7.94% to $1.5 million in 2026.
- Business Quant data shows RANI's Current Leases at $1.5 million in Q1 2026, $1.6 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 162.46 Mn | 162.46 Mn | - | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 718,000.00 |
| Sep 30, 2023 | 788,000.00 |
| Jun 30, 2023 | 856,000.00 |
| Mar 31, 2023 | 923,000.00 |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 984,000.00 |
| Jun 30, 2022 | 658,000.00 |
| Mar 31, 2022 | 650,000.00 |